China's GeneScience Pharma Participates in Rani's $53 Million Funding

China 's GeneScience Pharma was a new investor in Rani Therapeutics' latest $53 million fundraising. Rani, a Bay Area company, is developing pills that replace injectible delivery mechanisms to treat chronic diseases such as diabetes and arthritis. GeneScience hinted at a future tie-up between the two companies, though no agreement was announced. Rani will use the capital to build a manufacturing facility to supply products for clinical trials. More details.... Share this with colleagues: // //